Cheil General Hospital & Women's Healthcare Center   Report issue

Academic/Hospital Phase 2
Founded: Seoul Korea, Republic of (1963)

Organization Overview

First Clinical Trial
2012
NCT01634503
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

gx-188e (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma in Situ (Phase 2)

Cervical Intraepithelial Neoplasia (Phase 2)

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1